Find a Doctor

Dr. Philipp Bernhard Staber

Medical University Of Vienna

Bio


Philipp Staber is in Vienna, Austria. Dr. Staber is a global expert in Prolymphocytic Leukemia. They have been an author on 55 peer reviewed articles in the past 15 years. In particular, they have been an author on 3 peer reviewed articles regarding Prolymphocytic Leukemia.

Contact

Vienna, AT

Latest Advances


  • Condition: Classical Hodgkin Lymphoma And CD30+ Peripheral T-cell Lymphoma
  • Journal: European journal of haematology
  • Treatment Used: Brentuximab Plus Vedotin Plus Bendamustine
  • Number of Patients: 28
  • Published —
This study evaluated the effectiveness of Brentuximab Plus Vedotin Plus Bendamustine to treat patients with classical Hodgkin lymphoma (cHL) and CD30+ peripheral T-cell lymphoma (PTCL).

Clinical Trials


All Publications
View All


  • Sponsor: American Society of Hematology (ASH)
  • Event Name: American Society of Hematology Annual Meeting and Exposition 2020
  • Published —
Final Analysis of the Ro-CHOP Phase III Study (Conducted by LYSA): Romidepsin Plus CHOP in Patients with Peripheral T-Cell Lymphoma
  • Sponsor: American Society of Hematology (ASH)
  • Event Name: American Society of Hematology Annual Meeting and Exposition 2020
  • Published —
Core Binding Factor Leukemias Utilize a Physiologic Sense/Antisense Promoter Switch Employed By T-Cells

Contact

Vienna, AT

Insurance

Contact them to find out if they accept your insurance plan.